Home > Healthcare > Medical Devices > Diagnostic Devices > Point of Care Infectious Disease Testing Market
Point of Care Infectious Disease Testing Market Size
- Report ID: GMI11938
- Published Date: Oct 2024
- Report Format: PDF
Point of Care Infectious Disease Testing Market Size
The global Point of care infectious disease testing market size was valued at around USD 3.2 billion in 2023 and is estimated to grow at 6.9% CAGR from 2024 to 2032. Point-of-care (POC) infectious disease testing refers to diagnostic tests conducted at or near the site of patient care, rather than in centralized laboratories. These tests are designed to deliver rapid, on-the-spot results, allowing for immediate clinical decisions.
The increasing global burden of infectious diseases is a key driver of growth in the point-of-care (POC) infectious disease testing market. With the emergence of new infectious pathogens, the re-emergence of previously controlled diseases, and the growing threat of antimicrobial resistance, rapid and accurate diagnostics are critical for timely intervention. Diseases such as HIV, hepatitis, influenza, and tuberculosis continue to affect millions worldwide.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Point of Care Infectious Disease Testing Market Size in 2023: | USD 3.2 Billion |
| Forecast Period: | 2024 – 2032 |
| Forecast Period 2024 – 2032 CAGR: | 6.9% |
| 2024 – 2032 Value Projection: | USD 5.9 Billion |
| Historical Data for: | 2021-2023 |
| No. of Pages: | 137 |
| Tables, Charts & Figures: | 125 |
| Segments covered: | Product, Technology, Application, End Use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
For instance, in 2022, the World Health Organization (WHO) estimated that 10.6 million people globally contracted tuberculosis (TB), including 5.8 million men, 3.5 million women, and 1.3 million children. These figures highlight the widespread impact of the disease across various demographics. Moreover, the recent COVID-19 pandemic further underscored the urgent need for accessible testing solutions. As the spread of infectious diseases remains a significant public health challenge, the demand for POC testing has surged due to its ability to deliver fast, reliable results, enabling timely treatment and containment efforts.
Furthermore, technological innovations are driving growth in the point-of-care infectious disease testing market. Advances such as device miniaturization, digital platform integration, and the development of rapid, accurate molecular testing have improved ease of use, portability, and turnaround times. These improvements, particularly in automated devices with real-time data sharing, make point-of-care testing more efficient and widely adopted, especially in remote and resource-limited areas.
Frequently Asked Questions (FAQ) :
Point of Care Infectious Disease Testing Market Scope
